There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - House of Representatives

Short Title(s) as Introduced

Star Rating for Biosimilars Act

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To amend title XVIII of the Social Security Act to require the Secretary of Health and Human Services to add a new set of measures to the 5-star rating system under the Medicare Advantage program in order to encourage increased access to biosimilar biological products.


Actions Overview (1)

Date Actions Overview
10/08/2019Introduced in House

All Actions (6)

Date All Actions
10/18/2019Sponsor introductory remarks on measure. (CR H8232)
Action By: House of Representatives
10/09/2019Referred to the Subcommittee on Health.
Action By: Committee on Energy and Commerce
10/08/2019Referred to the Subcommittee on Health.
Action By: Committee on Ways and Means
10/08/2019Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Action By: House of Representatives
10/08/2019Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Action By: House of Representatives
10/08/2019Introduced in House
Action By: House of Representatives

Cosponsors (1)

* = Original cosponsor
CosponsorDate Cosponsored
Rep. Gibbs, Bob [R-OH-7]* 10/08/2019

Committees (2)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Related Documents
House Energy and Commerce10/08/2019 Referred to
House Energy and Commerce Subcommittee on Health10/09/2019 Referred to
House Ways and Means10/08/2019 Referred to
House Ways and Means Subcommittee on Health10/08/2019 Referred to

A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-congress measures.


Subjects (8)


Latest Summary (1)

There is one summary for H.R.4629. View summaries

Shown Here:
Introduced in House (10/08/2019)

Star Rating for Biosimilars Act

This bill requires the Centers for Medicare & Medicaid Services (CMS) to establish quality measures regarding biosimilar biological products under the five-star performance rating system for Medicare Advantage plans. The measures must assess the level of access that plans provide to covered biosimilars, including with respect to formularies, cost-sharing, and utilization management.

The CMS must also incorporate such measures into similar rating systems for plans under the Medicare prescription drug benefit.